Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bristol-Myers Squibb (BMY)
NYSE:BMY
Holding BMY?
Track your performance easily
BMY Analyst Ratings
Moderate Buy
5 Buy
9 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BMY Stock 12 Month Forecast
Average Price Target
$61.54
▲(4.39% Upside)
| Highest Price Target$70.00 | Average Price Target$61.54 | Lowest Price Target$39.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
Reiterated
01/28/25
Citi
Reiterated
01/28/25
Leerink Partners
Reiterated
01/26/25
Jefferies
Assigned
01/12/25
Bernstein
Reiterated
01/10/25
Truist Financial
Reiterated
01/07/25
J.P. Morgan
Reiterated
12/19/24
BMO Capital
Assigned
12/10/24
Berenberg Bank
Reiterated
12/10/24
Bank of America Securities
Initiated
12/10/24
Unknown Analyst
Not Ranked
CFRA
$60
Hold
1.78%
Upside
Downgraded
12/03/24
CFRA downgrades BMY (BMY) to Hold Strictly on Valuation, we think shares are fairly valued, continue to see BMY as better positioned for growthCFRA downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Buy to Hold with a price target of $60.00.
Wells Fargo
$52→$60
Hold
1.78%
Upside
Reiterated
11/18/24
Wells Fargo Sticks to Its Hold Rating for Bristol-Myers Squibb (BMY)
Wolfe Research
―
Hold
―
Initiated
11/14/24
Bristol Myers initiated with a Peer Perform at Wolfe ResearchBristol Myers initiated with a Peer Perform at Wolfe Research
Daiwa
$50→$65
Buy
10.26%
Upside
Upgraded
11/13/24
Daiwa Securities upgrades Bristol-Myers Squibb Co. (BMY) to Outperform (2)
UBS
$54→$60
Hold
1.78%
Upside
Reiterated
11/12/24
Bristol-Myers Squibb Co. (BMY) PT Raised to $60 at UBSUBS analyst Trung Huynh raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 (from $54.00) while maintaining a Neutral rating.
Best Analysts Covering Bristol-Myers Squibb
Which Analyst Should I Follow If I Want to Buy BMY and Sell After:
1 Month
xxx
Success Rate
10/18 ratings generated profit
Average Return
+1.09%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.56% of your transactions generating a profit, with an average return of +1.09% per trade.
3 Months
xxx
Success Rate
12/18 ratings generated profit
Average Return
+0.04%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +0.04% per trade.
1 Year
Success Rate
13/18 ratings generated profit
Average Return
+2.28%
reiterated a buy rating 7 days ago
Copying David Risinger's trades and holding each position for 1 Year would result in 72.22% of your transactions generating a profit, with an average return of +2.28% per trade.
2 Years
xxx
Success Rate
20/27 ratings generated profit
Average Return
+8.87%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 74.07% of your transactions generating a profit, with an average return of +8.87% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BMY Analyst Recommendation Trends
Rating
Sep 24
Oct 24
Nov 24
Dec 24
Jan 25
Strong Buy
0
0
0
0
0
Buy
7
6
12
10
12
Hold
21
21
25
22
14
Sell
9
7
8
5
4
Strong Sell
0
0
0
0
0
total
37
34
45
37
30
Each month's total comprises the sum of three months' worth of ratings.
BMY Financial Forecast
BMY Stock Forecast FAQ
What is BMY’s average 12-month price target, according to analysts?
Based on analyst ratings, Bristol-Myers Squibb’s 12-month average price target is $61.54.
What is BMY’s upside potential, based on the analysts’ average price target?
Bristol-Myers Squibb has 4.39% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BMY a Buy, Sell or Hold?
Bristol-Myers Squibb has a consensus rating of Moderate Buy which is based on 5 buy ratings, 9 hold ratings and 1 sell ratings.
What is Bristol-Myers Squibb’s price target?
The average price target for Bristol-Myers Squibb is $61.54. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $70.00 ,the lowest forecast is $39.00. The average price target represents 4.39% Increase from the current price of $58.95.
The highest analyst price target is $70.00 ,the lowest forecast is $39.00. The average price target represents 4.39% Increase from the current price of $58.95.
What do analysts say about Bristol-Myers Squibb?
Bristol-Myers Squibb’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of BMY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.